Business

Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, has received regulatory approval from the Indonesian Ministry of Health (Kementerian Kesehatan Republik Indonesia). This approval includes the Great Wall Microwave Therapeutic Instrument and the Great Wall Disposable Micr

articleBaird Medical Investment Holdings LtdMarch 10, 20255/company/baird-medical-investment-holdings-limited/news/baird-medical-secures-indonesian-regulatory-123000914
Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology

About this update from Baird Medical Investment Holdings Ltd

[{"type":"text","content":"NEW YORK, March 10, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, has received regulatory approval from the Indonesian Ministry of Health (Kementerian Kesehatan Republik Indonesia). This approval includes the Great Wall Microwave Therapeutic Instrument and the Great Wall Disposable Microwave Ablation Needle, laying the foundation for Baird Medical to introduce its advanced minimally invasive treatment solutions across Indonesia.","length":711,"tagName":"p"},{"type":"image","alt":"Baird Indonesian Certificate","displaySize":"","headline":null,"caption":"Baird Indonesian Certificate","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":300,"url":"https://media.zenfs.com/en/prnewswire.com/87517b9208e6462b65e1009a5ea29703"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SbnMgQ9CvqxeqblfwzJKTg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUyOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/87517b9208e6462b65e1009a5ea29703","width":400,"height":300}},"href":"https://mma.prnewswire.com/media/2637512/Baird_Indonesian_Certificate.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""This regulatory approval marks a significant step in our global strategic expansion and underscores our commitment to improving patient care with cutting-edge, minimally invasive technologies," said Haimei Wu, Chairwoman of Baird Medical.  "We look forward to collaborating with Indonesian healthcare providers and supporting them with innovative solutions that enhance precision, safety, and patient outcomes.","length":431,"tagName":"p"},{"type":"text","content":"Microwave ablation is a highly effective, minimally invasive procedure that uses targeted microwave energy to destroy abnormal tissue with minimal impact on surrounding areas. Recognized for its precision and faster recovery times, MWA is widely used for treating conditions such as thyroid nodules and tumors.","length":310,"tagName":"p"},{"type":"text","content":"With this regulatory milestone, Baird Medical is set to expand its distribution network and collabor...

More updates from Baird Medical Investment Holdings Ltd

Baird MedicalBaird Medical Investment Holdings Ltd.regulatory approvalmicrowave ablationsurgical instrumentsForward-Looking StatementsBaird Medical Investment Holdings LtdTulane Medical Centerminimally invasive